Adagio Medical Holdings (ADGM) Return on Capital Employed (2025 - 2026)

Adagio Medical Holdings (ADGM) reported Return on Capital Employed of 59.94% for Q1 2026, up 1025.0% on a YoY basis from 5.33% in Q1 2025, and up 19.81% sequentially from 74.75% in Q4 2025.

Adagio Medical Holdings (ADGM) Return on Capital Employed (2025 - 2026) Analysis & Trends

Adagio Medical Holdings (ADGM) has 2 years of Return on Capital Employed data on file, last reported at 59.94% in Q1 2026.

  • For the quarter ending Q1 2026, Return on Capital Employed rose 1025.0% year-over-year to 59.94%; the trailing twelve-month figure through Mar 2026 stood at 59.94% (up 1025.0% YoY), and the FY2025 full-year result was 58.19%, up 25620.0% from the prior year.
  • Return on Capital Employed climbed to 59.94% in Q1 2026, from 74.75% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 59.94% in Q1 2026 to a low of 92.72% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 9.61%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 12.24%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 8.02%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 9.62%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 11.13%
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 24.24%
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 8.38%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 9.30%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Adagio Medical Holdings 21.49 Mn 21.49 Mn - -59.94%

Historic Data

Download Data
DateValue
Mar 31, 2026 -59.94%
Dec 31, 2025 -74.75%
Sep 30, 2025 -92.72%
Jun 30, 2025 -68.79%
Mar 31, 2025 -70.19%